A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

NCT07235293 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: DSP107 + Atezolizumab
DRUG: Fruquintinib

Sponsor

Kahr Bio Australia Pty Ltd

Collaborators

Novotech (Australia) Pty Limited